Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
doi: 10.1111/j.1365-2362.2010.02338.x 64 BarbDBrilFKalavalapalliSCusiK
Mielgo-Ayuso J, et al
H., Mao, J
PubMed laboratory research record [PMID: 30024099] PubMed record related to this compound for laboratory literature review
First non-peptide oral GLP-1 for chronic weight management No injections required No fasting or food restrictions Demonstrated ~12.4% weight loss in Phase 3 trials This innovation has the potential to improve patient acceptance and adherence, making evidence-based obesity treatment more accessible than ever
![Victoza Lawsuit [2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2021/07/Victoza-Lawsuit-Alleged-Risks-and-Injuries-Linked-to-GLP-1-Weight-Loss-and-Diabetes-Drugs-Torhoerman-Law.jpg)
US$ 23.33
US$ 27.44
US$ 21.20
US$ 25.77
